首页|Zhongnan Hospital of Wuhan University Reports Findings in Cancer Biomarkers (CBi oProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Charac terization)
Zhongnan Hospital of Wuhan University Reports Findings in Cancer Biomarkers (CBi oProfiler: A Web and Standalone Pipeline for Cancer Biomarker and Subtype Charac terization)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Diagnostics and Screen ing - Cancer Biomarkers is the subject of a report. According to news reporting originating from Wuhan, People's Republic of China, by NewsRx correspondents, re search stated, "Cancer is a leading cause of death worldwide, and the identifica tion of biomarkers and subtypes that can predict the long-term survival of cance r patients is essential for their risk stratification, treatment, and prognosis. However, there are currently no standardized tools for exploring cancer biomark ers or subtypes." Our news editors obtained a quote from the research from the Zhongnan Hospital o f Wuhan University, "In this study, we introduced Cancer Biomarker and Subtype P rofiler (CBioProfiler), a web server and standalone application that includes tw o pipelines for analyzing cancer biomarkers and subtypes. The cancer biomarker p ipeline consists of five modules for identifying and annotating cancer survival- related biomarkers using multiple survival-related machine learning algorithms. The cancer subtype pipeline includes three modules for data preprocessing, subty pe identification using multiple unsupervised machine learning methods, as well as subtype evaluation and validation. CBioProfiler also includes CuratedCancerPr ognosisData, a novel R package that integrates reviewed and curated gene express ion and clinical data from 268 studies. These studies cover 43 common blood and solid tumors and draw upon 47,686 clinical samples."
WuhanPeople's Republic of ChinaAsiaBiomarkersCancerCancer BiomarkersCarcinoma BiomarkersComputersCyborgsDiagnostics and ScreeningEmerging TechnologiesGeneticsHealth and Medicin eMachine LearningOncologySoftwareWeb Server